Navigation Links
SyntheMed Receives CE Mark Approval for REPEL-GYN™
Date:5/24/2010

ISELIN, N.J., May 24 /PRNewswire-FirstCall/ -- SyntheMed, Inc. (OTC Bulletin Board: SYMD), a biomaterials company engaged in the development and commercialization of anti-adhesion products, today announced that REPEL-GYN™, the company's bioresorbable adhesion barrier film for the reduction of adhesions following gynecologic surgery, has received CE Mark approval in the European Union (EU).  CE Mark approval signifies that REPEL-GYN has met the essential requirements of the European Union Medical Devices Directive and enables the company to begin marketing the product to reduce the incidence, severity and extent of post-operative adhesion formation in patients undergoing gynecologic surgery.  

The formation of adhesions (scar tissue) between organs in the pelvic cavity is a frequent, undesirable result of gynecologic surgery.  Pelvic adhesions can cause the patient to endure chronic pain, small bowel obstruction and infertility.  The presence of adhesions is also a complicating factor in repeat caesarian sections.  There are an estimated 2 million gynecologic procedures performed annually in the EU and other international markets in which the patients are at risk of developing adhesion-related complications.

Robert P. Hickey, President and CEO, SyntheMed, Inc., stated, "We are very pleased to have received regulatory approval to expand the use of our proprietary bioresorbable polymer film in the EU markets.  REPEL-GYN is similar to REPEL-CV® Adhesion Barrier which is currently marketed internationally for use in all cardiac surgical procedures and in pediatric cardiac surgery in the United States.  We are currently evaluating our options on the marketing of REPEL-GYN throughout the EU either through a corporate partn
'/>"/>

SOURCE SyntheMed, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. SyntheMed Receives Brazilian Regulatory Approval for REPEL-CV(TM)
2. SyntheMed Receives Russian Regulatory Approval for REPEL-CV(TM)
3. SyntheMed Receives US Patent on Novel Polymer Technology
4. SyntheMed Receives Frost & Sullivan Health Innovation Award Nomination
5. SyntheMed Receives Australian Regulatory Approval for REPEL-CV(R)
6. FDA Approves SyntheMeds REPEL-CV(R) Adhesion Barrier for Use in Pediatric Cardiac Surgery
7. SyntheMed Announces FDA Clearance of SinusShield(TM)
8. SyntheMed Announces New Management Appointments
9. SyntheMed Completes $4.0 Million Equity Placement
10. SyntheMed To Present at the AdvaMed 2008 MedTech Conference
11. SyntheMed to Present at Canaccord Adams Small-Cap Orthopedics Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/2/2015)... 2, 2015  Spherix Incorporated (Nasdaq: SPEX ) -- an ... monetization of intellectual property, today announced a litigation update. ... v. Verizon Services Corp. et al. , Case No. ... Eastern District of Virginia , the ... interpreting certain key claims in favor of the Defendants ...
(Date:7/1/2015)... PARK, N.C. and PARIS ... research firm AgBiome, and Genective, key developer of ... accelerate the discovery of new generations of insect ... for insect control to counter the realities of ... with Genective, aligning AgBiome,s unique insect control technology ...
(Date:7/1/2015)...  Axovant Sciences Ltd. (NYSE:  AXON), a leading ... dementia, today announced that the company will host ... p.m. EDT following its presentation of RVT-101 clinical ... (AAIC). The event will include ... Lawrence Friedhoff , Chief Development Officer, will present ...
(Date:7/1/2015)... ... July 01, 2015 , ... ... combat pathogen transmission. CTI’ new Medical Joysticks have an impermeable molecular barrier ... have an operator control device that will increase healthcare worker safety and reduce ...
Breaking Biology Technology:Spherix Issues A Litigation Update 2Spherix Issues A Litigation Update 3AgBiome and Genective collaborate to create novel insect-resistant crops 2Axovant Sciences To Host Investor Briefing And Live Webcast During AAIC 2015 Meeting 2Axovant Sciences To Host Investor Briefing And Live Webcast During AAIC 2015 Meeting 3Sanitized Medical Joysticks for a Safer and Healthier Work Environment 2
... Uroplasty, Inc. (Amex:,UPI) announced today that it will ... on Monday, November 10, 2008 at the New York,Palace ... Chief Executive,Officer and Medi Jiwani, Vice President and Chief ... financial,performance at 4:55 p.m. Eastern Time., Attendance at ...
... DIEGO, Nov. 4 ADVENTRX Pharmaceuticals,Inc. (Amex: ANX ... of ADVENTRX, is scheduled to present at the Rodman ... scheduled to present,on Tuesday, November 11th, 2008 at 2:50 ... place November 10-12, 2008 at the,Palace Hotel in New ...
... technology is one of the rapidly growing markets in life science ... is projected to reach $2.2 billion. Major factors that continue to ... the existing and emerging technologies. , ... San Jose, ...
Cached Biology Technology:Uroplasty to Present at the Rodman & Renshaw 10th Annual Healthcare Conference in New York 2World Gene Amplification Technologies Market to Reach $2.2 Billion by 2015, According to New Report by Global Industry Analysts, Inc. 2World Gene Amplification Technologies Market to Reach $2.2 Billion by 2015, According to New Report by Global Industry Analysts, Inc. 3
(Date:6/15/2015)... 2015 According to a new ... (Rule-Based, Statistical, and Hybrid), Technologies (Recognition, IVR, OCR, Pattern ... by MarketsandMarkets, The Natural Language Processing Market is expected ... 18.4% for the forecast period 2015-2020. ... igures spread   through 155 P ages ...
(Date:6/15/2015)... NXT-ID, Inc. (NASDAQ: NXTD ) ("NXT-ID" or the ... commerce market, announces that its leading payment security technology, the ... Experience! @ NYC June 18th. Digital Experience! @ ... in technology to over 300 of the top media covering ... Pavilion in New York City from ...
(Date:6/11/2015)... Va. , June 11, 2015 ... technology, announced today that its IdentityX Mobile Authentication ... (Fast IDentity Online) Alliance is an industry consortium ... open standards for simpler, stronger authentication.  In order ... must pass a rigorous series of tests that ...
Breaking Biology News(10 mins):Natural Language Processing Market Worth $13.4 Billion by 2020 2Natural Language Processing Market Worth $13.4 Billion by 2020 3Natural Language Processing Market Worth $13.4 Billion by 2020 4Natural Language Processing Market Worth $13.4 Billion by 2020 5Wocket Smart Wallet Exhibiting at Pepcom Digital Experience! @ NYC June 18th 2Wocket Smart Wallet Exhibiting at Pepcom Digital Experience! @ NYC June 18th 3Daon's IdentityX Mobile Authentication Platform One of First Products to be Certified by FIDO Alliance 2
... of social and ethical challenges associated with research into, ... (9 June). The report, commissioned by the Biotechnology and ... Panel, is part of its programme to ensure that ... area of science and technology. Embargoed copies of the ...
... single organ may contain more than one type of adult ... the versatile cells to replace damaged tissue as a treatment ... of geneticist Mario Capecchi, the University of Utah,s Nobel Laureate. ... Nature Genetics, Capecchi and geneticist Eugenio Sangiorgi report that when ...
... to understand the design principles and origins of the ... evolutionary origins of the brain and how it evolved ... The research suggests that it is not size alone ... increasingly sophisticated molecular processing of nerve impulses allowed development ...
Cached Biology News:Synthetic Biology: funders move to address social and ethical challenges 2Caution on stem cell therapy 2Caution on stem cell therapy 3Caution on stem cell therapy 4Origins of the brain 2Origins of the brain 3